177Lu-EVG321

N/A

Report date: 2025/11/24 17:31:58

NME

Base Information

Drug Name177Lu-EVG321

Drug Alias Name177Lu-EVG321EVG-321

ClassificationRadiation-emitting products > Radioactive therapeutic agentRadiation-emitting products > Nuclides > Lutetium > 177LuSmall molecules > Synthetic peptide > Peptide drug conjugate (PDC) +[4]

Mechanisms of ActionCholecystokinin B receptor binders

TargetsCholecystokinin B receptor

Therapy Area/IndicationsSmall Cell Lung Carcinoma

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryUnited States

CombinationsNo

Global Highest StatusPreclinical

Highest Status in ChinaN/A

Originator CompaniesMedical University Of Innsbruck

China Registration ClassN/A

Develop Information

Active CompaniesEvergreen Theragnostics Inc

Inactive CompaniesN/A

Active IndicationsSmall Cell Lung Carcinoma

Inactive IndicationsN/A

Other Information

ATC CodeN/A